These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 742869)

  • 21. Pharmacokinetics of azlocillin in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Godin M; Fillastre JP
    Antimicrob Agents Chemother; 1980 Mar; 17(3):344-9. PubMed ID: 7425600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of azlocillin in healthy subjects.
    Leroy A; Humbert G; Fillastre JP
    Scand J Infect Dis Suppl; 1981; 29():49-54. PubMed ID: 6947405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of piperacillin in patients with moderate renal failure and in patients undergoing hemodialysis.
    Giron JA; Meyers BR; Hirschman SZ; Srulevitch E
    Antimicrob Agents Chemother; 1981 Feb; 19(2):279-83. PubMed ID: 6214987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The biliary excretion and pharmacokinetics of mezlocillin in jaundiced patients with external bile drainage.
    Dooley JS; Gooding A; Hamilton-Miller JM; Brumfitt W; Sherlock S
    Liver; 1983 Aug; 3(4):201-6. PubMed ID: 6672502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-dependent pharmacokinetics of mezlocillin in rats.
    Jungbluth GL; Jusko WJ
    Antimicrob Agents Chemother; 1989 Jun; 33(6):839-43. PubMed ID: 2764534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of cefotiam administered intravenously and intramuscularly to healthy adults.
    Brisson AM; Bryskier A; Millerioux L; Fourtillan JB
    Antimicrob Agents Chemother; 1984 Oct; 26(4):513-8. PubMed ID: 6097166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of temocillin in volunteers.
    Hampel B; Feike M; Koeppe P; Lode H
    Drugs; 1985; 29 Suppl 5():99-102. PubMed ID: 4029032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of coadministration on the pharmacokinetics of mezlocillin and cefotaxime in healthy volunteers and in patients with renal failure.
    Rodondi LC; Flaherty JF; Schoenfeld P; Barriere SL; Gambertoglio JG
    Clin Pharmacol Ther; 1989 May; 45(5):527-34. PubMed ID: 2721108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of mezlocillin in patients with kidney impairment: special reference to hemodialysis and dosage adjustments in relation to renal function.
    Brogard JM; Comte F; Spach MO; Lavillaureix J
    Chemotherapy; 1982; 28(5):318-26. PubMed ID: 6216076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative pharmacokinetics of two multiple-dose mezlocillin regimens in normal volunteers.
    Colaizzi PA; Coniglio AA; Poynor WJ; Vishniavsky N; Karnes HT; Polk RE
    Antimicrob Agents Chemother; 1986 Nov; 30(5):675-8. PubMed ID: 3800343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of saturable clearance during high-dose mezlocillin therapy.
    Drusano GL; Forrest A; Fiore D; Auger F; Caplan ES
    Antimicrob Agents Chemother; 1984 Nov; 26(5):686-8. PubMed ID: 6517555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose dependence of piperacillin pharmacokinetics.
    Bergan T; Williams JD
    Chemotherapy; 1982; 28(3):153-9. PubMed ID: 6212203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biliary elimination of mezlocillin: an experimental and clinical study.
    Brogard JM; Kopferschmitt J; Arnaud JP; Dorner M; La Villaureix J
    Antimicrob Agents Chemother; 1980 Jul; 18(1):69-76. PubMed ID: 6448023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of impaired renal function, hemodialysis, and peritoneal dialysis on the pharmacokinetics of mezlocillin.
    Kampf D; Schurig R; Weihermüller K; Förster D
    Antimicrob Agents Chemother; 1980 Jul; 18(1):81-7. PubMed ID: 6448024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of mezlocillin during haemodialysis.
    Thorsteinsson SB; Steingrimsson O; Asmundsson P; Bergan T
    Scand J Infect Dis Suppl; 1981; 29():59-63. PubMed ID: 6458883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacokinetic studies on broad spectrum antibiotic combinations of penicillin and oxacillin in normal volunteers (author's transl)].
    Adam D; Bauer W; Seitz B; Voigt I
    Arzneimittelforschung; 1979; 29(11):1769-804. PubMed ID: 543889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative review of two new wide-spectrum penicillins: mezlocillin and piperacillin.
    Russo J; Russo ME
    Clin Pharm; 1982; 1(3):207-16. PubMed ID: 6224627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of mezlocillin and sulbactam under continuous veno-venous hemodialysis (CVVHD) in intensive care patients with acute renal failure.
    Rohde B; Werner U; Hickstein H; Ehmcke H; Drewelow B
    Eur J Clin Pharmacol; 1997; 53(2):111-5. PubMed ID: 9403281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mezlocillin kinetics in hepatic insufficiency.
    Bunke CM; Aronoff GR; Brier ME; Sloan RS; Luft FC
    Clin Pharmacol Ther; 1983 Jan; 33(1):73-6. PubMed ID: 6217018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of the pharmacokinetics and dose dependency of azlocillin in normal subjects and patients with renal insufficiency.
    Bergan T
    J Antimicrob Chemother; 1983 May; 11 Suppl B():101-14. PubMed ID: 6352598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.